Open-Label, Long-Term Treatment Study, to Assess the Long-Term Safety and Tolerability and Efficacy of Neramexane in Patients With Subjective Tinnitus

NCT00827008 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

821

Enrollment

INDUSTRY

Sponsor class

Conditions

Subjective Tinnitus

Interventions

DRUG: Neramexane mesylate

Sponsor

Merz Pharmaceuticals GmbH